Medtech co Neuronetics rises on upbeat Q4 results

Neuronetics

05/03/2024 14:48

** Shares of medtech firm Neuronetics Inc  STIM.O  rise 7.5%
to $3  
    ** Co reports Q4 revenue of $20.31 mln, beating analysts'
estimates of $19.85 mln- LSEG data 
    ** Reports Q4 adj. loss of 19 cents per share, vs. analysts'
estimates of loss of 26 cents per share 
     ** Co had cash and cash equivalent of $59.7 mln as of
December 31, 2023 
    ** Sees 2024 total revenue in the range of $78 mln to $80
mln vs analysts estimates of $78.64 mln  
    ** Including session moves, stock has fallen 46.4% in the
last 12 months 

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))